fig8
![MASLD-mimicking microenvironment drives an aggressive phenotype and represses IDH2 expression in hepatocellular carcinoma](https://image.oaes.cc/706611a5-ba05-4871-82f2-8606e6ffb377/hr30140.fig.8.jpg)
Figure 8. Immunohistochemical staining of IDH2 in HCC patient tissues and parenchyma. When more than 10% of the hepatocytes are stained (brown), defined as positive for IDH2 (A); others were defined as negative (B). Comparison of the ratios of positive staining for IDH2 in parenchyma and HCC tumor tissues (C); and in tumor samples of patients with/without microvascular invasion (D)